Recalls / Active ingredient / Ipratropium Bromide
Ipratropium Bromide
6 FDA drug recalls involving the active ingredient “Ipratropium Bromide”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-03-26 | Class II | Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged | Cipla USA, Inc. |
| 2022-04-13 | Class II | Ipratropium Bromide Inhalation Solution, 0.02%, 0.5 mg/2.5 mL, packaged in 25-count box (25 x 2.5 mL sterile u | Mckesson Medical-Surgical Inc. Corporate Office |
| 2022-04-13 | Class III | Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution 3mL vial, packaged in a) 30-count | Mckesson Medical-Surgical Inc. Corporate Office |
| 2022-01-26 | Class II | Ipratropium Bromide and Albuterol Sulfate Inhalation Solution (0.5 mg/3 mg per 3 mL), 60 x 3 mL Sterile Unit-D | CARDINAL HEALTHCARE |
| 2015-08-21 | Class II | Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL Sterile Unit-Do | Nephron Pharmaceuticals Corp. |
| 2015-07-24 | Class II | COMBIVENT RESPIMAT (ipratropium bromide and albuterol) Inhalation Spray, 20 mcg/100 mcg per actuation*, 4 Gram | Boehringer Ingelheim Roxane Inc |